Inocras and Broad Institute Researchers Will Release Novel Insights From TCGA Cancer Whole-Genome Analysis at AACR Annual Meeting 2026, Empowering a New Era of Precision Oncology Comprehensive ...
Association of neighborhood-level factors with access to genetic testing in patients with resectable pancreatic ductal adenocarcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
The first resource containing high-resolution DNA sequencing data for over 37,000 children and parents collected over multiple decades from across the UK is now available to researchers worldwide. The ...
EV-302: Long-term subgroup analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or ...
Caris Life Sciences (NasdaqGS:CAI) published a pivotal study on its Caris Lookback Program confirming its effectiveness in finding patients eligible for newly approved targeted therapies. The company ...
Scientists at the Baylor College of Medicine and collaborating institutions used complementary approaches that integrate exome sequencing and evolutionary action machine learning to identify protein ...
Global NICU Genetic Testing Market OverviewThe global NICU Genetic Testing Market is projected to grow at a CAGR of ...
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...
SAN DIEGO--(BUSINESS WIRE)--Researchers at Inocras, a bioinformatics-led precision health company harnessing the power of whole-genome sequencing (WGS) data and proprietary analytics, and the Broad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results